Abstract:Background Genetic and environmental factors contribute to the pathogenesis of schizophrenia (SZ) and bipolar disorder (BD). Among genetic risk groups stratified by combinations of Polygenic Risk Score (PRS) deciles for SZ, BD and SZ versus BD, genetic SZ risk groups had high SZ risk and prominent cognitive impairments. Furthermore, epigenetic alterations are implicated in these disorders. However, it was unclear whether DNA Methylation Risk Scores (MRSs) for SZ risk derived from blood and brain tissues were associated with SZ risk, particularly the PRS-stratified genetic SZ risk group. Methods Epigenome-wide association studies (EWASs) of SZ risk in whole blood were preliminarily conducted between 66 SZ patients and 30 healthy controls (HCs) and among genetic risk groups (individuals with low genetic risk for SZ and BD in HCs (n=30) and in SZ patients (n=11), genetic BD risk in SZ patients (n=25) and genetic SZ risk in SZ patients (n=30)) stratified by combinations of PRSs for SZ, BD and SZ versus BD. Next, differences in MRSs based on independent EWASs of SZ risk in whole blood, postmortem frontal cortex (FC) and superior temporal gyrus (STG) were investigated among our case-control and PRS-stratified genetic risk status groups. Results Among case-control and genetic risk status groups, 33 and 351 genome-wide significant differentially methylated positions (DMPs) associated with SZ were identified, respectively, many of which were hypermethylated. Compared with the low genetic risk in HCs group, the genetic SZ risk in SZ group had 39 genome-wide significant DMPs, while the genetic BD risk in SZ group had only six genome-wide significant DMPs. The MRSs for SZ risk derived from whole blood, FC and STG were higher in our SZ patients than in HCs in whole blood and were particularly higher in the genetic SZ risk in SZ group than in the low genetic risk in HCs and genetic BD risk in SZ groups. Conversely, the MRSs for SZ risk based on our whole-blood EWASs among genetic risk groups were also associated with SZ in the FC and STG. There were no correlations between the MRSs and PRSs. Conclusions These findings suggest that the MRS is a potential genetic marker in understanding SZ, particularly in patients with a genetic SZ risk.

Genome-wide methylome analyses reveal novel epigenetic regulation patterns in schizophrenia and bipolar disorder

DNA Methylation in Schizophrenia: Progress and Challenges

Chromatin Profiling in Human Neurons Reveals Aberrant Roles for Histone Acetylation and BET Family Proteins in Schizophrenia

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Altered DNA methylation of the Alu Y subfamily in schizophrenia and bipolar disorder

Hypermethylation of serotonin transporter gene in bipolar disorder detected by epigenome analysis of discordant monozygotic twins

Enrichment of Cis -Regulatory Gene Expression SNPs and Methylation Quantitative Trait Loci among Bipolar Disorder Susceptibility Variants

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Hypomethylation of LINE-1 elements in schizophrenia and bipolar disorder

Allele-specific DNA methylation maps in monozygotic twins discordant for psychiatric disorders reveal that disease-associated switching at the EIPR1 regulatory loci modulates neural function

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

Methylomic Alteration in Peripheral Blood Lymphocytes of Prodromal Stage and First-Episode Chinese Han Schizophrenia Patients

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

Genome-wide DNA methylation risk scores for schizophrenia derived from blood and brain tissues further explain the genetic risk in patients stratified by polygenic risk scores for schizophrenia and bipolar disorder

The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients

Genes implicated by a methylome-wide schizophrenia study in neonatal blood show differential expression in adult brain samples

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Genetic and Epigenetic Regulation on the Transcription of GABRB2: Genotype-dependent Hydroxymethylation and Methylation Alterations in Schizophrenia.